Global Intravenous (IV) Iron Drugs Market - Global Industry Analysis and Forecast to 2020
Persistence Market Research
Global Intravenous (IV) Iron Drugs Market Global Industry Analysis and Forecast to 2020
Persistence Market Research
1
Global Intravenous (IV) Iron Drugs Market - Global Industry Analysis and Forecast to 2020 Persistence Market Research Released New Market Report on “Global Intravenous (IV) Iron Drugs Market - Global Industry Analysis and Forecast to 2020”.
Iron is one of the most important mineral present inside the human body. It carries oxygen throughout the body via blood, which is further utilized by cells and tissue to get energy for all vital biological processes. Moreover, deficiency of iron leads to severe health problems, such as anemia and also affects mental or other memory functions in youths. To overcome this problem, oral iron supplements are recommended to maintain iron level in the body. However, in some cases, oral administrations are not capable to maintain the iron level in the body. For these cases, IV iron therapy is used to as part of which iron is directly injected inside the body with a needle through a vein.
The global market of IV iron drugs is categorized based on various product types and by therapeutic area. The product type segment is further sub-segmented in low molecular weight iron dextran, ferric gluconate, iron sucrose and ferric carboxylmaltose. Ferric carboxymaltose is the fastest growing sub-segment. Moreover, the therapeutic area segment includes nephrology, gynecology, gastroenterology, oncology, chronic heart failures and surgeries. Nephrology represents the largest segment for use of IV iron drug and therapies. Under geographic analysis, North America is the largest market for IV iron drugs followed by Europe and Asia. In North America, the U.S. represents the largest market for IV iron drugs. In Europe, Germany, France and the U.K. covers the major share of IV iron drugs market.
Browse the full “Global Intravenous (IV) Iron Drugs Market” report at http://www.persistencemarketresearch.com/market-research/intravenous-iron-drugs-market.asp
Global IV iron drugs market is witnessing a significant growth due to it improves quality of treatment outside the dialysis, increasing number of dialysis patients, growing number of diabetic patients worldwide and growing aging population. Moreover, increasing cases of hypertension, rising investment in healthcare sector, higher spending on medicine are also supporting in growth of IV iron drugs market. In addition, dialysis clinics are gaining importance in IV iron drugs market, as they form a very significant customer group for intravenous iron drugs. These types of dialysis clinics also administer iron dosages and attract patients for reliable and safe IV iron drug administration.
However, stringent regulations and side-effects associated with IV iron products impede growth of the market. Several government associations, such as FDA and European Medicines Agency have stringent
Persistence Market Research
2
Global Intravenous (IV) Iron Drugs Market - Global Industry Analysis and Forecast to 2020 regulations for IV iron drugs approval and usage. These approval processes are complex and time taking, where every new drug is required to fulfill the mandatory stringent regulations. Moreover, nausea, muscle cramps, vomiting, constipation, joint pain, headache, back pain and cough are some of the major sideeffects of IV iron drugs.
Request For Full Report With TOC Visit:http://www.persistencemarketresearch.com/marketresearch/intravenous-iron-drugs-market.asp
Some of the key players operating in the IV iron drugs market are Actavis, Inc., AMAG Pharmaceuticals, Inc., Galenica Ltd., Fresenius Medical Care AG & Co. KGaA, Vifor Pharma Ltd., American Regent, Inc., Luitpold Pharmaceuticals, Inc., Pharmacosmos A/S, Rockwell Medical Technologies, Inc., and Sanofi. Key points covered in the report:1. Report segments the market on the basis of types, application, products, technology, etc (as applicable) 2. The report covers geographic segmentation • North America • Europe • Asia • RoW 3. The report provides the market size and forecast for the different segments and geographies for the period of 2010 to 2020 4. The report provides company profiles of some of the leading companies operating in the market 5. The report also provides porters five forces analysis of the market.
Browse the full “All Upcoming Persistence Market's ” report at http://www.persistencemarketresearch.com/forthcoming-reports.asp
About Us: Persistence Market Research is a global market research firm specializing- syndicated research, custom research, and consulting services At Persistence Market Research (PMR), we are in the business of accelerating your business. As a fullservice market research firm, we stand committed to bringing more accuracy and speed to your business decisions. From ready-to-purchase market research reports to customized global research solutions, our engagement models are highly flexible without compromising on our deep-seated research values. Briefly stated, our mission is to give you access to forecasts and trends analyses that put you on the path to profitability.
Persistence Market Research
3
Global Intravenous (IV) Iron Drugs Market - Global Industry Analysis and Forecast to 2020
PMR’s Services Go Beyond Gleaning Data Most enterprises believe that IT and databases are enough to make an accurate decision. While we do not dispute that, consider this: How long does it take to make an accurate and strategic million-dollar decision? We strive to deliver both even with demanding deadlines.
Contact Us: Addie Thomes 305 Broadway, 7th Floor, New York City, NY 10007, United States. USA/Canada Toll Free Number. 1-800-961-0353 E-mail: Sales@persistencemarketresearch.com Web : http://www.persistencemarketresearch.com/ Press Release : http://www.persistencemarketresearch.com/media-releases.asp Articles : http://www.persistencemarketresearch.com/articles.asp
Persistence Market Research
4